Loading...
Projects / Programmes source: ARIS

Biološke značilnosti raka glave in vratu in uspeh zdravljenja (Slovene)

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
B007  Biomedical sciences  Medicine (human and vertebrates) 
B610  Biomedical sciences  Otorhinolaryngology, audiology, auditive system and speech 
Keywords
Head and neck carcinoma, ploidy, proliferative activity, oncogenes, angiogenesis, postoperative irradiation, Mitomycin C, Bleomycin
Evaluation (rules)
source: COBISS
Researchers (11)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  00702  PhD Marjan Budihna  Oncology  Researcher  2000 - 2002  125 
2.  16048  PhD Igor Fajdiga  Oncology  Researcher  2000 - 2002  113 
3.  05318  PhD Berta Jereb  Oncology  Researcher  2000 - 2002  350 
4.  12224  PhD Borut Kragelj  Oncology  Researcher  2000 - 2002  81 
5.  09762  PhD Hotimir Lešničar  Oncology  Researcher  2000 - 2002  125 
6.  02130  PhD Alojz Šmid  Oncology  Head  2000 - 2002  215 
7.  05316  PhD Erika Šoba-Podobnik  Oncology  Researcher  2000 - 2002  52 
8.  13156  PhD Lorna Zadravec Zaletel  Oncology  Researcher  2000 - 2002  251 
9.  11747  PhD Branko Zakotnik  Oncology  Researcher  2000 - 2002  425 
10.  02132  PhD Miha Žargi  Oncology  Researcher  2000 - 2002  392 
11.  02133  PhD Avgust Župevc  Oncology  Researcher  2000 - 2002  78 
Organisations (2)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0302  Institute of Oncology Ljubljana  Ljubljana  5055733000  15,789 
2.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,953 
Abstract
Authors intend to study correlation between the DNA ploidy, proliferative activity of tumor cells, expression of oncogenes and their products, tumor angiogenesis and treatment results of patients with head and neck carcinoma with poor prognostic factors. Al patients will be primarily operated on and postoperativly irradiated. Patients will be randimized so that a half of them will receive together with the postoperative irradiation also Mitomycin C and Bleomycin.
Views history
Favourite